Public Profile

Cuu Long Pharmaceutical Joint Stock Company

Cuu Long Pharmaceutical Joint Stock Company, commonly referred to as Cuu Long Pharma, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 2001, the company has made significant strides in the production and distribution of high-quality pharmaceutical products across various regions in Vietnam. Cuu Long Pharma focuses on the development of generic medicines, herbal products, and dietary supplements, setting itself apart with a commitment to innovation and quality. The company has achieved notable milestones, including certifications from international quality standards, which bolster its reputation in the market. With a strong market position, Cuu Long Pharmaceutical is recognised for its extensive product range and dedication to improving healthcare outcomes. Its unique offerings and strategic operational approach have solidified its status as a trusted name in the Vietnamese pharmaceutical landscape.

DitchCarbon Score

How does Cuu Long Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

10

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Cuu Long Pharmaceutical Joint Stock Company's score of 10 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.

47%

Cuu Long Pharmaceutical Joint Stock Company's reported carbon emissions

Cuu Long Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not have available data on carbon emissions, as no specific emissions figures have been reported. Consequently, there are no defined reduction targets or climate commitments outlined by the company at this time. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to establish measurable climate goals. However, without specific data or commitments from Cuu Long Pharmaceutical, it is unclear how they are addressing their carbon footprint or contributing to climate action initiatives.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cuu Long Pharmaceutical Joint Stock Company's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Cuu Long Pharmaceutical Joint Stock Company is headquartered in VN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Cuu Long Pharmaceutical Joint Stock Company is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Imexpharm Corporation

VN
Chemicals nec
Updated 4 days ago

Traphaco Joint Stock Company

VN
Chemicals nec
Updated 4 days ago

Fresenius Kabi Aktiengesellschaft

DE
Real estate services (70)
Updated 4 days ago
DitchCarbon Score

Pymepharco Joint Stock Company

VN
Chemicals nec
Updated 4 days ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers